Mining electronic health records: challenges and impact

被引:1
作者
Menasalvas, Ernestina [1 ]
Rodriguez-Gonzalez, Alejandro [1 ]
Gonzalo, Consuelo [1 ]
机构
[1] Univ Politecn Madrid, Ctr Tecnol Biomed, Madrid, Spain
来源
2018 14TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS) | 2018年
基金
欧盟地平线“2020”;
关键词
data mining; NLP; electronic health records; name entity recognition; CELL LUNG-CANCER; IDENTIFICATION; ALK;
D O I
10.1109/SITIS.2018.00119
中图分类号
TP31 [计算机软件];
学科分类号
081202 ; 0835 ;
摘要
Big data applications in the Healthcare Sector can provide a high potential for improving the overall efficiency and quality of care delivery. In the health care sector though, big data analytics has still to address several technical requirements, being unstructured data analysis one of them. Unstructured data represents a powerful untapped resource-one that has the potential to provide deeper insights into data and ultimately help drive competitive advantage. In this talk some of the most common challenges of processing such data to extract useful knowledge will be analyzed. In particular, we will deal with the following challenges: i) clinical narratives preprocessing using NLP, ii) name entity recognition, iii) semantic enrichment, iv) integration of the results. We will focus on the real use cases in which we are working in the frame of a European H2020 project called IASIS. In fact, we will analyze the challenges of analyzing reports and notes of patients suffering from Alzheimer's disease disease and lung cancer to extract patterns (survival, treatment, antecedents, ... ) that can help physicians to get insights for better management of the disease.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 25 条
[1]  
Bethune Gillian, 2010, J Thorac Dis, V2, P48
[2]   The Unified Medical Language System (UMLS): integrating biomedical terminology [J].
Bodenreider, O .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D267-D270
[3]  
Brierley JD, 2017, International union against cancer, V8th
[4]   Testing for ROS1 in non-small cell lung cancer: a review with recommendations [J].
Bubendorf, Lukas ;
Buettner, Reinhard ;
Al-Dayel, Fouad ;
Dietel, Manfred ;
Elmberger, Goran ;
Kerr, Keith ;
Lopez-Rios, Fernando ;
Marchetti, Antonio ;
Oz, Buge ;
Pauwels, Patrick ;
Penault-Llorca, Frederique ;
Rossi, Giulio ;
Ryska, Ales ;
Thunnissen, Erik .
VIRCHOWS ARCHIV, 2016, 469 (05) :489-503
[5]   Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution [J].
Buccheri, G ;
Ferrigno, D ;
Tamburini, M .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (07) :1135-1141
[6]   Targeted therapy for non-small cell lung cancer: current standards and the promise of the future [J].
Chan, Bryan A. ;
Hughes, Brett G. M. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (01) :36-54
[7]  
Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523
[8]  
Grose T.J., 2002, MASTERING XMI JAVA P, V21
[9]   Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system [J].
Iwahara, T ;
Fujimoto, J ;
Wen, DZ ;
Cupples, R ;
Bucay, N ;
Arakawa, T ;
Mori, S ;
Ratzkin, B ;
Yamamoto, T .
ONCOGENE, 1997, 14 (04) :439-449
[10]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139